Urology · Jesup, GA
NPI
1154315877
Since 2005
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
825 S 1st St
Jesup, GA, 31545
Phone (912) 427-8033
Groups this clinician bills Medicare through
Medicare paid, 2024
$423K
6,402 services
Medicare patients, 2024
1,036
Average age 75
Drug cost, 2024
$834K
6,347 prescriptions
Company payments, 2025
$407
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark D Byron was code 81002 (clinical chemistry), 2,533 times for 974 patients. In total Mark D Byron billed 6,402 services in 51 codes, and Medicare paid $423K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-06-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 81002 Clinical Chemistry | Office | 2,533 | 974 | $3.38 | $8,567 |
| 99214 Office E&M - Established | Office | 2,367 | 905 | $88.34 | $209K |
| 99204 Office E&M - New | Office | 225 | 225 | $111.22 | $25K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 208 | 37 | $132.37 | $28K |
| 52281 Calculus Removal - Urinary | Office | 170 | 148 | $234.06 | $40K |
| 96402 Chemotherapy Administration | Office | 161 | 37 | $26.21 | $4,219 |
| 51610 Standard X-ray | Facility | 113 | 100 | $25.16 | $2,843 |
| 50590 Calculus Removal - Urinary | Facility | 103 | 90 | $559.56 | $58K |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 91 | 29 | $0.35 | $31.9 |
| J1580 Injection, garamycin, gentamicin, up to 80 mg | Office | 49 | 37 | $1.98 | $97.07 |
| 52332 Cystourethroscopy | Facility | 44 | 34 | $83.32 | $3,666 |
| 76872 Ultrasound - Nonspecific | Office | 43 | 36 | $99.90 | $4,296 |
| 55700 Other Organ Systems | Office | 34 | 34 | $163.60 | $5,562 |
| 99231 Hospital E&M - Subsequent | Facility | 30 | 17 | $39.27 | $1,178 |
| 99233 Hospital E&M - Subsequent | Facility | 29 | 27 | $84.27 | $2,444 |
By year: 2022 $406K for 6,650 services; 2023 $468K for 7,268 services; 2024 $423K for 6,402 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 2,533 | 974 | $3.38 | $8,567 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark D Byron prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,078 prescriptions and refills. In total Mark D Byron wrote 6,347 Medicare prescriptions that cost $834K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,078 | 2,694 | 358 | $14K |
| Doxazosin Mesylate Generic | 914 | 2,407 | 268 | $14K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 503 | 513 | 322 | $8,909 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 403 | 907 | 118 | $6,945 |
| Finasteride Generic | 390 | 1,022 | 122 | $5,014 |
| Ciprofloxacin Hcl Generic | 389 | 560 | 219 | $4,426 |
| Gemtesa Vibegron | 364 | 568 | 80 | $274K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 318 | 318 | 200 | $1,743 |
| Cephalexin Generic | 269 | 491 | 136 | $2,758 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 205 | 208 | 148 | $770 |
| Myrbetriq Mirabegron | 143 | 221 | 34 | $100K |
| Methenamine Hippurate Generic | 123 | 220 | 39 | $11K |
| Trimethoprim Generic | 114 | 258 | 40 | $9,754 |
| Fesoterodine Fumarate Er Fesoterodine Fumarate | 111 | 170 | 41 | $9,573 |
| Bicalutamide Generic | 86 | 158 | 25 | $3,348 |
Brand drugs: - claims; generic drugs: 5,645 claims; opioid claims: 416.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark D Byron $407 ($407 in general payments such as food, travel and fees) from 5 companies. The largest payer was Teleflex LLC with $217.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.